Newsroom
As a wholly owned subsidiary of ResMed, Propeller brings broad respiratory care expertise, digital therapeutic coverage, and scale globally.
Press Releases
Global list of executives including Propeller Health’s SVP of Marketing recognizes leading disruptive customer experience initiatives
(SAN DIEGO, Calif.) January 25, 2024 – Propeller Health, a ResMed company, and leader in precision digital health and therapeutics, today announced its SVP of Marketing, VJ Bala, was named to Constellation Research’s 2024 AX100, an elite list of innovative and disruptive leaders transforming customer and employee experiences — and businesses — around the world. The AX100 will be inducted and celebrated at the Ambient Experience Summit in Austin, Texas on February 27, 2024.
As SVP of Marketing at Propeller Health, VJ Bala and his team commercialize connected medical devices with software and services for patients and physicians to manage chronic conditions; design and deliver innovative consumer, physician, and client experiences; and foster an industry ecosystem to expand and accelerate digital adoption. For more than 30 years, VJ has created pioneering digital products and experiences in healthcare, life sciences, public sector, and other industries.
(SAN DIEGO, Calif.) January 10, 2024 — Propeller Health, a ResMed company and leader in precision digital health for the management and treatment of chronic respiratory diseases, is pleased to announce that its General Manager, Susa Monacelli, has been elected to the Digital Therapeutics Alliance (DTA) Board of Directors.
Monacelli’s election to the board underscores her dedication to the advancement of digital therapeutics and her career-long commitment to improving patient care through innovative, accessible technology solutions.
“The DTA Board of Directors has a unique and critical role in shaping the future of digital therapeutics,” said Aaron Gani, Chairman of the DTA Board and CEO at RealizedCare. With diverse representation from companies applying a range of business models to unlock the value of DTx — including Rx, OTC, value-based, and integrated virtual care models — our board brings unique perspectives that enrich our understanding. This diversity will ensure that we successfully navigate the many complexities of the industry comprehensively, fostering innovation and advancing the transformative potential of digital therapeutics to fundamentally improve outcomes and access to evidence-based care.”
Awarded winning title in the health equity category of the Digital Health Hub Foundation’s 2023 Awards.
(SAN DIEGO, Calif.) October 9, 2023 — Propeller Health announces its selection as a winner of the Digital Health Awards, presented by the Digital Health Hub Foundation and hosted at the HLTH global healthcare conference. Propeller earned the top honor in the health equity category’s Best-in-Class track.
This achievement recognizes Propeller’s commitment to realizing its mission of uplifting every person living with chronic disease so they can take control of their health and live a better life. The Digital Health Hub Foundation Awards applaud the prowess of Propeller in harnessing digital innovations to enhance healthcare services and elevate patient outcomes.
New collaboration will integrate Propeller’s platform with UC Davis Health’s electronic health record system to efficiently provide clinicians data on patient’s disease management
(SACRAMENTO, Calif.) — UC Davis Health and Propeller Health have announced a new collaboration that will offer personalized treatment for high-risk patients with asthma and chronic obstructive pulmonary disease (COPD) aiming to improve their health outcomes.
As part of the collaboration, UC Davis Health will provide the Propeller program – including sensors, mobile app, web portal, and personalized support – to eligible patients, with eventual expansion to patients in other UC locations and UC affiliates. The sensors attach to a patient’s inhaler to capture unique signals that record events, such as medication usage or respiration. This data will be transmitted directly to UC Davis Health’s Epic® electronic health record (EHR) system to support patient enrollment and remote patient monitoring via single sign-on.
Propeller Health’s precision digital health platform wins the Clinical Information Management category of the Fierce Healthcare Innovation Awards 2022. The platform enables physicians and care teams to proactively identify at-risk patients in between routine visits and provide more timely clinical interventions.
MADISON, WI, November 15, 2022 – Propeller Health, a leader in precision digital health, today announces its platform for chronic condition management is a Fierce Healthcare Innovation Awards 2022 winner. The program showcases outstanding innovation that is driving improvements and transforming the industry. The Propeller Digital Health Platform for Chronic Condition Management (The Propeller Platform”) enables proactive clinical care by collecting objective patient data and displaying resulting insights directly within a provider’s native workflow.
At Propeller, data itself is only the beginning – activating it is what powers patient care,” said Susa Monacelli, Propeller Health General Manager. By surfacing the data within clinicians’ existing workflow through EHR integrations, we enable their treatment decisions and help identify at-risk patients. Patient self-management coupled with proactive clinician intervention helps improve clinical outcomes and, in turn, economic value for health systems, payers, and patients. Our focus is to do this across connected medications and therapies to change healthcare at scale.”
Announces integrations with multiple leading Electronic Health Record (EHR) systems, introduces a new solution to enable Remote Therapeutic Monitoring (RTM) by healthcare providers, and launches digital platform updates to enable respiratory care at home, in-clinic, and on-the-go.
MIAMI, March 7, 2022 – Propeller Health, a leader in digital health for asthma and chronic obstructive pulmonary disease (COPD), today announced three exciting updates and new solutions to bring its clinically proven, FDA-cleared platform to more patients, providers and health systems.